期刊文献+

Anxa2和P-gp蛋白相互作用对多药耐药乳腺癌细胞迁移与侵袭影响的研究 被引量:6

Effect of the interaction between Anxa2 and P-gp on migration and invasion of multidrug resistant human breast cancer cells
原文传递
导出
摘要 目的:探讨Anxa2和P-gp蛋白相互作用对多药耐药乳腺癌细胞迁移与侵袭的影响。方法:采用小干扰RNA技术下调人多药耐药乳腺癌细胞MCF-7/ADR中P-gp的表达,并筛选稳定的单克隆细胞株;利用噻唑蓝(MTT)比色法和Transwell实验研究P-gp的表达对MCF-7及其耐药细胞MCF-7/ADR的增殖、迁移和侵袭能力的影响;利用免疫沉淀和免疫荧光分析多药耐药细胞中Anxa2和P-gp的相互关系。结果:蛋白印迹法检测发现,Anxa2和P-gp在耐药乳腺癌细胞中均高表达;MCF-7/ADR与其亲本细胞MCF-7相比,迁移和侵袭能力明显增强;MCF-7/ADR细胞中P-gp的表达被抑制后,其迁移和侵袭能力显著下降,并且差异有统计学意义,P<0.05。免疫沉淀证实,Anxa2和P-gp之间存在相互作用;免疫荧光发现,Anxa2和P-gp在细胞膜上存在很好的共定位。结论:降低P-gp的表达可以明显抑制耐药乳腺癌细胞MCF-7/ADR的迁移和侵袭能力,Anxa2和P-gp之间存在较好的共定位和相互作用。提示Anxa2和P-gp的相互作用有可能对增强多药耐药乳腺癌细胞的侵袭转移能力起到一个重要的作用。 OBJECTIVE: To investigate the effect of Anxa2 Interacting with P-gp on the migration and invasion of the multidrug resistant(MDR) human breast cancer cells MCF-7/ADR.METHODS: One pair of small interfering RNA(siRNA) targeting P-gp was transfected into MCF-7/ADR cells and monoclonal cell strains were screened.The expression of P-gp was detected by Western blotting.The activity of proliferation was examined by MTT.The migration capacity and the invasion ability were detected by Transwell chambers.The interaction between Anxa2 and P-gp was examined by immunoprecipitation and Immunofluorescence confocal microscopy analysis.RESULTS:Abxa2 and P-gp were expressed in the breast cancer cells.The migration and ivnation of MCF-7/ADR inereased significantly compared with MCF-7.P-gp expression was significantly knocked down and there was a notably decrease in migration and invasion capability of MDR breast cancer cells(P〈0.05).There was a close interaction between Anxa2 and P-gp.CONCLUSIONS: Knockdown of P-gp can inhibite migration and invasion capability of MCF-7/ADR cells notably.Moreover,it is discovered that Anxa2 interacted with P-gp by immunoprecipitation and immunofluorescence confocal microscopy analysis indicating that Anxa2 interacting with P-gp may plays an important role in the enhanced invasiveness of the multidrug resistant human breast cancer cells.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第3期166-171,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81071731) 教育部长江学者和创新团队发展计划项目(IRT1076)
关键词 乳腺肿瘤 Anxa2 P-GP 多药耐药 肿瘤浸润 breast neoplasms Anxa2 P-gp multidrug resistance neoplasm invasiveness
作者简介 【第一作者简介】张海嫦,女,江西高安人,硕士,主要从事肿瘤发生和发展以及转移分子机制的研究工作。Tel:86—22—23340123 E—mail:zhanghaichang2006@163.com 【通讯作者简介】牛瑞芳,女,山西阳泉人,博士,研究员,教授,硕士生导师,主要从事肿瘤发生和发展以及转移分子机制的研究工作。Tel:86—22--23340123—5549 E—mail:niurf1982@yahoo.com.cn
  • 相关文献

参考文献15

  • 1Parkin DM,Bray F,Ferlay J. Global cancer statistics 2002[J].CA:A Cancer Journal for Clinicians,2005,(02):74-108.doi:10.3322/canjclin.55.2.74.
  • 2赵宁,张忠涛,屈翔,王宇.肺耐药蛋白在乳腺癌中的表达及临床意义[J].首都医科大学学报,2009,30(5):699-702. 被引量:3
  • 3Yang JM,Xu ZD,Wu H. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells[J].Molecular Cancer Research,2003,(06):420-427.
  • 4Reimers N,Zafrakas K,Assmann V. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells[J].Clinical Cancer Research,2004,(10):3422-3428.
  • 5Toole BP,Marieb EA,Zoltan-Jones A. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production[J].Cancer Research,2004,(04):1229-1232.doi:10.1158/0008-5472.CAN-03-2832.
  • 6Miletti-Gonzalez KE,Chen S,Muthukumaran N. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer[J].Cancer Research,2005,(15):6660-6667.
  • 7Molinari A,Colone M,Calcabrini A. The multidrug transporter P-glycoprotein:A mediator of melanoma invasion[J].J Investigative Dermatol,2008,(04):957-971.
  • 8徐晓妹,林惠忠,鲁杰,张日民,黄维青,林兆武.多药耐药基因MDR1及P-gp蛋白在乳腺癌组织中的表达及临床意义[J].肿瘤防治杂志,2005,12(15):1150-1153. 被引量:10
  • 9董维峰,汪昱.Annexins在恶性肿瘤中的表达及其临床意义[J].中国现代普通外科进展,2010,13(4):302-305. 被引量:6
  • 10Zhang N,Zhang F,Zhang L. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells[J].Journal of Proteome Research,2009,(11):5041-5047.doi:10.1021/pr900461c.

二级参考文献20

  • 1Hung KS,Howng SL.Prognostic significance of annexin VII expression in glioblastomas multiforme in humans[J].中国神经肿瘤杂志,2003,1(4):199-199. 被引量:14
  • 2穆殿斌,仲伟霞,贺爱丽,刘自芬.乳腺癌P-gp、LRP、GST-π、TOPO-Ⅱ的表达及其与术前化疗的关系[J].实用医技杂志,2004,11(08B):1530-1532. 被引量:1
  • 3谭敏,宾晓农,何青莲,刘鹏熙,胥健敏,赵虹,杨海峰.乳腺癌组织中耐药相关基因表达的研究[J].广州中医药大学学报,2005,22(3):200-202. 被引量:7
  • 4Scheper R J,Broxterman H J,Scheffer G L,et al.Overexpression of a Mr 110,000 resicular protein in non-P-glocoprotein mediated multidrug resistance[J].Cancer Res,1993,53:1475-1479.
  • 5Schneider J,Gonzalez-Roces S,Pollan M,et al.Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy[J].Breast Cancer Res,2001,3:183-191.
  • 6Meschini S,Marra M,Calcabrini A,et al.Role of the lung resistance correlated protein(LRP) in the drug sensitivity of cultured tumor cells[J].Toxicol In Vitro,2002,16:389-398.
  • 7Pohl G,Filipits M,Suchomel R W,et al.Expression of lung resistance protein(LRP) in primary breast cancer[J].Anticancer Res,1999,19:5051-5059.
  • 8Filipits M,Pohl G,Stranzl T,et al.Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia[J].Blood,1998,91:1508-1513.
  • 9Oide H,Minegishi A,Kobayashi S,et al.Evaluation of p21 and lung resistance protein(LRP) as a factor suggesting breast cancer recurrence[J].Nippon Geka Gekkai Zasshi,2000,101:242-248.
  • 10Cui Q,Matsusue K,Toh Y,et al.Assignment of the metastasis-associated gene (Mta1) to mouse chromosome band 12F and the metastasis-associated gene 2 (Mta2) to mouse chromosome band 19B by fluorescence in situ hybridization.Cytogenet Cell Genet,2001,94(324):246-247.

共引文献17

同被引文献77

  • 1周建军,乐秀芳,韩家娴,杨蔚怡.评价抗癌物质活性的改良MTT方法[J].中国医药工业杂志,1993,24(10):455-457. 被引量:108
  • 2李宏建,李贵海,孙付军,尹格平.苦参碱对肿瘤细胞获得性多药耐药的逆转作用[J].中国医院药学杂志,2005,25(5):389-391. 被引量:13
  • 3李艳红,王永华,李燕,杨凌.MDR1基因多态性及其临床相关性研究进展(英文)[J].Acta Genetica Sinica,2006,33(2):93-104. 被引量:11
  • 4鄂征.组织培养和分子细胞学技术[M].北京:北京出版社,1994.100.
  • 5Mckee T, Mckee JR. Biochemistry an introduction. 2ed. [ M ] . Mc Graw-Hill Companies Inc, 1999 : 132-134.
  • 6Tsurno T, Lida H, Tsukagoshi S. Overcoming of vincristine resista- nce in p388 leukemia in vivo and in vitro through enhanced cytoto- xicity of vincristine and vinblas-tine by verapami [ J ] . Cancer Res, 1981, 41 ( 5 ) : 1967.
  • 7Muller C, Goubin F, Ferrandis E, et al. Evidence for transcriptional control of human mdr 1 gene expression by verapamil in multidrug- resistant leukemic cells [ J ] . Mol Pharmacol, 1995, 47 ( 1 ) : 51- 56.
  • 8Fojo T, Bates S. Strategies for reversing drug resistance [ J ] . Oncogene, 2003, 22 : 7512-7523.
  • 9Sharifi N, Qi J, Bane S, et al. Survivin is not induced by novel taxanes [J]. Mol Pharm,2010,7(6):2216-2223.
  • 10Zhang LQ,Wang J, Jiang F, et al. Prognostic value oi Survivin in patients with non-small cell lung carcinoma: A systematic review with Meta-analysis [J]. PLOS ONE, 2012,7(3) : e34100.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部